How does Sitagliptin enhance incretin hormone activity, and what role does this enhancement play in improving glycemic control for diabetic patients?
Share
Sign Up to our social questions and Answers Engine to ask questions, answer people’s questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
Sitagliptin inhibits the enzyme DPP-4, which degrades incretin hormones. Enhanced incretin levels improve insulin release and decrease glucagon, aiding glycemic control in diabetics.